Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer”
The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressiv...
| Published in: | Clinical and Translational Radiation Oncology |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-11-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630825001235 |
| _version_ | 1849286362957611008 |
|---|---|
| author | Parth Aphale Himanshu Shekhar Shashank Dokania |
| author_facet | Parth Aphale Himanshu Shekhar Shashank Dokania |
| author_sort | Parth Aphale |
| collection | DOAJ |
| container_title | Clinical and Translational Radiation Oncology |
| description | The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressive reduction in SUVmax values across follow-up intervals [1]. While the findings reinforce the utility of PSMAPET/CT as a potential biomarker for local tumor control, certain methodological and interpretive issues merit deeper consideration. |
| format | Article |
| id | doaj-art-a297557dfdee4d57bb2da26b2ac137d1 |
| institution | Directory of Open Access Journals |
| issn | 2405-6308 |
| language | English |
| publishDate | 2025-11-01 |
| publisher | Elsevier |
| record_format | Article |
| spelling | doaj-art-a297557dfdee4d57bb2da26b2ac137d12025-09-12T04:22:22ZengElsevierClinical and Translational Radiation Oncology2405-63082025-11-015510103110.1016/j.ctro.2025.101031Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer”Parth Aphale0Himanshu Shekhar1Shashank Dokania2Corresponding author.; Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, IndiaDr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, IndiaDr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, IndiaThe recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressive reduction in SUVmax values across follow-up intervals [1]. While the findings reinforce the utility of PSMAPET/CT as a potential biomarker for local tumor control, certain methodological and interpretive issues merit deeper consideration.http://www.sciencedirect.com/science/article/pii/S2405630825001235PSMA-PET/CTSUVmaxPSMA nadir |
| spellingShingle | Parth Aphale Himanshu Shekhar Shashank Dokania Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” PSMA-PET/CT SUVmax PSMA nadir |
| title | Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” |
| title_full | Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” |
| title_fullStr | Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” |
| title_full_unstemmed | Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” |
| title_short | Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer” |
| title_sort | comment on psma response evaluation in follow up psma pet ct after stereotactic ablative body radiotherapy sabr for oligometastases in prostate cancer |
| topic | PSMA-PET/CT SUVmax PSMA nadir |
| url | http://www.sciencedirect.com/science/article/pii/S2405630825001235 |
| work_keys_str_mv | AT parthaphale commentonpsmaresponseevaluationinfollowuppsmapetctafterstereotacticablativebodyradiotherapysabrforoligometastasesinprostatecancer AT himanshushekhar commentonpsmaresponseevaluationinfollowuppsmapetctafterstereotacticablativebodyradiotherapysabrforoligometastasesinprostatecancer AT shashankdokania commentonpsmaresponseevaluationinfollowuppsmapetctafterstereotacticablativebodyradiotherapysabrforoligometastasesinprostatecancer |